Publications 2026

Lorenzen S, Goetze TO, Thuss-Patience PC, Riera-Knorrenschild J, Goekkurt E, Dechow TN, Ettrich TJ, Hofheinz RD, Luley KB, Pink D, Lindig U, Folprecht G, Schuch G, Bitzer M, Heinemann V, Angermeier S, Bolling C, Loose M, Junge S, Pauligk C, Al-Batran SE. First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial. Nat Commun. 2026 Feb 27;17(1):2072. doi: 10.1038/s41467-026-69622-7. PMID: 41760643; PMCID: PMC12948978

Kreher KL, Dörfler J, Büntzel J, Büntzel J, Hübner J. Reliability of Results from Randomized Studies and Systematic Reviews in Acupuncture: A Methodological Review for Acupuncture Against Symptoms of Breast Cancer Care. In Vivo. 2026 Mar-Apr;40(2):726-747. doi: 10.21873/invivo.14234. PMID: 41760339; PMCID: PMC12949905

Tharmaseelan H, Sgonina LM, Bühnen I, Schnetzke U, Meißner J, Sellmayr M, Beverungen D, Hellmuth JC, Puthenparambil J, Zamrik T, Ferdinandus J, Shumilov E, Kerkhoff A, Melchardt T, Bröckelmann PJ, Kobe C, Borchmann P, Von Tresckow B. Anti-programmed cell death protein 1-based salvage therapy for relapsed/refractory Hodgkin lymphoma: a multicenter real-world analysis. Haematologica. 2026 Feb 26. doi: 10.3324/haematol.2025.288996. Epub ahead of print. PMID: 4174288

Lauseker M, Sacha T, Klamova H, Yakoleva J, Lomaia E, Milojkovic D, Fabisch C, Nicolini FE, Olsson-Stromberg U, Zackova D, Lewandowski K, Ernst P, Castagnetti F, Hirschbühl K, Zupan I, Voskanyan A, Gołos A, Frietsch JJ, Gil J, Faber E, Krause SW, Parry A, Saussele S, Heibl S, Franke GN, Casado LF, Paczkowska E, Hebart H, Eder M, Anhut P, Trautmann-Grill K, Szczepanek E, Südhoff T, Patkowska E, Kiani A, Ernst T, Apperley J, Mayer J, Hochhaus A, Pfirrmann M, Brioli A. Development of a prognostic scoring system for chronic myeloid leukemia in blast phase. Leukemia. 2026 Feb 19. doi: 10.1038/s41375-026-02875-9. Epub ahead of print. PMID: 41714405

Sitte HH, Hübner J, Aust N, Weisshäupl V, Ernst E. Trials and tribulations of responsible people trying to uphold scientific standards. Res Integr Peer Rev. 2026 Feb 16;11(1):5. doi: 10.1186/s41073-026-00191-5. PMID: 4169274

Obstfelder E, Herrmann J, Vučinić V, Hochhaus A, Schnetzke U, Eigendorff F. Tisagenlecleucel yields superior patient-reported health-related quality of life compared to autologous stem cell transplantation in patients with relapsed/refractory large B-cell lymphomas. Ann Hematol. 2026 Feb 5;105(3):88. doi: 10.1007/s00277-026-06840-5. PMID: 41639434

Voigtländer S, Dörfler J, Hübner J. Acupuncture as treatment of cancer-therapy induced fatigue: a critical systematic review with a focus on the methodological assessment of blinding. J Cancer Res Clin Oncol. 2026 Jan 8;152(1):37. doi: 10.1007/s00432-025-06395-4. PMID: 41507508; PMCID: PMC12783427

Crodel CC, Kohnle C, Radsak MP, Nückel H, Jilg S, Hochhaus A, Heidel FH, Hübner J. Patient-reported outcomes regarding the use of complementary and alternative medicine (CAM) in BCR::ABL1-negative myeloproliferative neoplasias. J Cancer Res Clin Oncol. 2026 Jan 20;152(1):41. doi: 10.1007/s00432-025-06421-5. PMID: 41559233; PMCID: PMC12819938

Fleischmann M, Hansen O, Voigtländer D, Bechwar J, Schwietzer L-J, Bahr S, et al. Targeting MCL-1 and MAPK overcomes venetoclax resistance in FLT3-ITD-positive AML cells harbouring activating PTPN11 (SHP-2) mutations. Br J Haematol. 2026; 00: 1–11. https://doi.org/10.1111/bjh.70344

Ernst P, Lohse C, Lauseker M, Geißler J, le Coutre P, Brümmendorf TH, Saußele S, Burchert A, Franke GN, La Rosée P, Brioli A, Schenk T, Fabisch C, Ernst T, Mehlkop G, Hochhaus A. Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective. Leukemia. 2026 Jan;40(1):29-36. doi: 10.1038/s41375-025-02826-w. Epub 2025 Dec 19. PMID: 41419606; PMCID: PMC12789025

Bill M, Eckardt JN, Döhner K, Röhnert MA, Rausch C, Metzeler KH, Spiekermann K, Stasik S, Wurm AA, Sauer T, Scholl S, Schnetzke U, Hochhaus A, Crysandt M, Brümmendorf TH, Krug U, Wörmann B, Einsele H, Hiddemann W, Görlich D, Sauerland C, Steffen B, Neubauer A, Burchert A, Schäfer-Eckart K, Berdel WE, Schliemann C, Krause SW, Hänel M, Hanoun M, Kaufmann M, Fransecky L, Braess J, Schetelig J, Middeke JM, Bullinger L, Heuser M, Thol F, Serve H, Baldus CD, Platzbecker U, Müller-Tidow C, Válka J, Šrámek J, Weinbergerova B, Mayer J, Dumas PY, Bertoli S, Delabesse E, Récher C, Pigneux A, Herold T, Ganser A, Döhner H, Bornhäuser M, Thiede C, Röllig C. Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients. Leukemia. 2026 Jan;40(1):63-71. doi: 10.1038/s41375-025-02781-6. Epub 2025 Oct 27. PMID: 41145671; PMCID: PMC12789037

Salmon M, Naumann N, Rinke J, Meggendorfer M, Radia D, Pomfret M, Ernst T, Hochhaus A, Reiter A, Tapper WJ, White H, Cross NCP. Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes. Leukemia. 2026 Jan;40(1):37-46. doi: 10.1038/s41375-025-02801-5. Epub 2025 Nov 18. PMID: 41254115; PMCID: PMC12789007

Truger M, Meggendorfer M, Walter W, Hutter S, Alsdorf W, Massenkeil G, Martens UM, Kern W, Hörst K, Kühn C, Reiter A, Hochhaus A, Haferlach T. Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencing. Leukemia. 2026 Jan;40(1):55-62. doi: 10.1038/s41375-025-02820-2. Epub 2025 Dec 19. PMID: 41419605; PMCID: PMC12789012

Hochhaus A., Gale RP: 40 years of LEUKEMIA. Leukemia (2026) 40:1–2; https://doi.org/10.1038/s41375-025-02840-y

Fischer M, Büntzel J, Hübner J. Social and psychological effects of a stoma on the sexuality and self-image of patients. Int J Colorectal Dis. 2026 Jan 20;41(1):39. doi: 10.1007/s00384-026-05091-0. PMID: 41559477

Burchert A, Nicolini FE, le Coutre P, Saussele S, Hochhaus A, Tuere E, Metzelder SK, Pauck K, Garn H, Raifer H, Huber M, Gattermann N, Crysandt M, Schafhausen P, Bormann M, Radsak MP, Guerci-Bresler A, Illmer T, Goebeler ME, Herhaus P, Teichmann LL, Franke GN, Lang F, Krause SW, Möhle R, Klausmann M, Stegelmann F, Lutz C, Etienne G, Stoltefuß A, Göthert JR, Ernst T, Abu-Samra M, Höffkes HG, Neubauer A, Wang Y, Weiland P, Otto C, Kiessler L, Weber T, Kroning L, Nist A, Stiewe T, Hehlmann R, Aminossadati B, Wittenberg M, Winterstein K, Oellerich T, Lechner M, Pfirrmann M, Schade-Brittinger C, Klemm P, Michel C. Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX). Leukemia. 2026 Feb;40(2):410-417. doi: 10.1038/s41375-025-02859-1. Epub 2026 Jan 12. PMID: 41526617; PMCID: PMC12875868

Witt, N., Mathies, V. Ernährung in der Prähabilitation. Onkologie (2026). https://doi.org/10.1007/s00761-025-01896-w

Anika Wolff, Jutta Hübner, Jens Büntzel and Judith Büntzel: “Psychotropic Medicinal Plant Use in Oncology: A Dual-Cohort Analysis and Its Implications for Anesthesia and Perioperative Care”, Appl. Sci. 2026, 16(1), 481; https://doi.org/10.3390/app16010481

Dendorfer SM, Schmidt-Brücken K, Kramer M, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Hänel M, Hanoun M, Kaufmann M, Weinbergerova B, Schäfer-Eckart K, Sauer T, Neubauer A, Burchert A, Baldus CD, Mertová J, Jost E, Niemann D, Novák J, Krause SW, Scholl S, Hochhaus A, Held G, Szotkowski T, Rank A, Schmid C, Fransecky L, Kayser S, Schaich M, Fiebig F, Haake A, Schetelig J, Middeke JM, Stölzel F, Platzbecker U, Thiede C, Müller-Tidow C, Berdel WE, Ehninger G, Mayer J, Serve H, Bornhäuser M, Röllig C. Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy. Am J Hematol. 2026 Mar;101(3):512-520. doi: 10.1002/ajh.70160. Epub 2026 Jan 5. PMID: 41492073; PMCID: PMC12869000

Schenk T, Fabisch C, Ernst T, Ernst P, Saussele S, Žáčková D, Mayer J, Klamová H, Hochhaus A; German CML Study Group and the Czech Leukemia Study Group. Ponatinib for CML patients in routine clinical practice: the PONDEROSA study. Ann Hematol. 2026 Jan 15;105(1):9. doi: 10.1007/s00277-026-06788-6. PMID: 41535610; PMCID: PMC12804319